Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on February 28, 2005

Circulation. 2005
Published online before print February 28, 2005, doi: 10.1161/01.CIR.0000158478.29668.9B
A more recent version of this article appeared on March 22, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
111/11/1377    most recent
01.CIR.0000158478.29668.9Bv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spuentrup, E.
Right arrow Articles by Günther, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spuentrup, E.
Right arrow Articles by Günther, R. W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Chest Pain
*MRI Scans
*Pulmonary Embolism
Related Collections
Right arrow Cardiovascular imaging agents/Techniques
Right arrow Imaging
Right arrow Arterial thrombosis
Right arrow Fibrinogen/fibrin
Right arrow Pulmonary circulation and disease
Right arrow Acute coronary syndromes
Right arrow CT and MRI

Submitted on October 26, 2004
Revised on December 1, 2004
Accepted on December 2, 2004

Molecular Magnetic Resonance Imaging of Coronary Thrombosis and Pulmonary Emboli With a Novel Fibrin-Targeted Contrast Agent

Elmar Spuentrup MD*, Arno Buecker MD, Marcus Katoh MD, Andrea J. Wiethoff PhD, Edward C. Parsons Jr PhD, Rene M. Botnar PhD, Robert M. Weisskoff PhD, Philip B. Graham PhD, Warren J. Manning MD, and Rolf W. Günther MD

From the Department of Diagnostic Radiology, Aachen Technical University, Aachen, Germany (E.S., A.B., M.K., R.W.G.); EPIX Pharmaceuticals, Cambridge, Mass (A.J.W., E.C.P., P.B.G.); and Departments of Medicine (Cardiovascular Division) (R.M.B., W.J.M.) and Radiology (W.J.M.), Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, Mass.

* To whom correspondence should be addressed. E-mail: spuenti{at}rad.rwth-aachen.de.

Background--The differential diagnosis of acute chest pain is challenging, especially in patients with normal ECG findings, and may include coronary thrombosis or pulmonary emboli. The aim of this study was to investigate the novel fibrin-specific contrast agent EP-2104R for molecular targeted MR imaging of coronary thrombosis and pulmonary emboli.

Methods and Results--Fresh clots were engineered ex vivo from human blood and delivered in the lungs and coronary arteries of 7 swine. Subsequent molecular MR imaging was performed with a navigator-gated free-breathing and cardiac-triggered 3D inversion-recovery black-blood gradient-echo sequence before and after systemic administration of 7.5 µmol/kg EP-2104R. Two swine served as the control group. MR images were analyzed by 2 investigators, and contrast-to-noise ratio and gadolinium concentration in the clots were assessed. Before contrast media application, no thrombi were visible. After contrast administration, all 32 pulmonary emboli, 3 emboli in the right heart, and 5 coronary thrombi were selectively visualized as white spots with a mean contrast-to-noise ratio of 32±19. The average gadolinium concentration from all 3 types of thrombi was 144±79 µmol/L.

Conclusions--Molecular MR imaging with the fibrin-targeted contrast-agent EP-2104R allows selective visualization of acute coronary, cardiac, and pulmonary thrombi.


Key words: contrast media • coronary vessels • fibrin • magnetic resonance imaging • thrombosis




This article has been cited by other articles:


Home page
J Am Coll Cardiol ImgHome page
R.-J. J.H.M. Miserus, M. V. Herias, L. Prinzen, M. B.I. Lobbes, R.-J. Van Suylen, A. Dirksen, T. M. Hackeng, J. W.M. Heemskerk, J. M.A. van Engelshoven, M. J.A.P. Daemen, et al.
Molecular MRI of Early Thrombus Formation Using a Bimodal {alpha}2-Antiplasmin-Based Contrast Agent
J. Am. Coll. Cardiol. Img., August 1, 2009; 2(8): 987 - 996.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Lockie, E. Nagel, S. Redwood, and S. Plein
Use of Cardiovascular Magnetic Resonance Imaging in Acute Coronary Syndromes
Circulation, March 31, 2009; 119(12): 1671 - 1681.
[Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
M. Nahrendorf, D. E. Sosnovik, B. A. French, F. K. Swirski, F. Bengel, M. M. Sadeghi, J. R. Lindner, J. C. Wu, D. L. Kraitchman, Z. A. Fayad, et al.
Multimodality Cardiovascular Molecular Imaging, Part II
Circ Cardiovasc Imaging, January 1, 2009; 2(1): 56 - 70.
[Full Text] [PDF]


Home page
CirculationHome page
C. von zur Muhlen, D. von Elverfeldt, J.A. Moeller, R.P. Choudhury, D. Paul, C.E. Hagemeyer, M. Olschewski, A. Becker, I. Neudorfer, N. Bassler, et al.
Magnetic Resonance Imaging Contrast Agent Targeted Toward Activated Platelets Allows In Vivo Detection of Thrombosis and Monitoring of Thrombolysis
Circulation, July 15, 2008; 118(3): 258 - 267.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. A. Jaffer, P. Libby, and R. Weissleder
Molecular Imaging of Cardiovascular Disease
Circulation, August 28, 2007; 116(9): 1052 - 1061.
[Full Text] [PDF]


Home page
RadiologyHome page
T. Saam, T. S. Hatsukami, N. Takaya, B. Chu, H. Underhill, W. S. Kerwin, J. Cai, M. S. Ferguson, and C. Yuan
The Vulnerable, or High-Risk, Atherosclerotic Plaque: Noninvasive MR Imaging for Characterization and Assessment
Radiology, July 1, 2007; 244(1): 64 - 77.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. P. Stracke, M. Katoh, A. J. Wiethoff, E. C. Parsons, P. Spangenberg, and E. Spuntrup
Molecular MRI of Cerebral Venous Sinus Thrombosis Using a New Fibrin-Specific MR Contrast Agent
Stroke, May 1, 2007; 38(5): 1476 - 1481.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. E. Sosnovik, M. Nahrendorf, and R. Weissleder
Molecular Magnetic Resonance Imaging in Cardiovascular Medicine
Circulation, April 17, 2007; 115(15): 2076 - 2086.
[Full Text] [PDF]


Home page
CMAJHome page
E. Escolar, G. Weigold, A. Fuisz, and N. J. Weissman
New imaging techniques for diagnosing coronary artery disease.
Can. Med. Assoc. J., February 14, 2006; 174(4): 487 - 495.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Sirol, V. Fuster, J. J. Badimon, J. T. Fallon, J.-F. Toussaint, and Z. A. Fayad
Chronic Thrombus Detection With In Vivo Magnetic Resonance Imaging and a Fibrin-Targeted Contrast Agent
Circulation, September 13, 2005; 112(11): 1594 - 1600.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Spuentrup, B. Fausten, S. Kinzel, A. J. Wiethoff, R. M. Botnar, P. B. Graham, S. Haller, M. Katoh, E. C. Parsons Jr, W. J. Manning, et al.
Molecular Magnetic Resonance Imaging of Atrial Clots in a Swine Model
Circulation, July 19, 2005; 112(3): 396 - 399.
[Abstract] [Full Text] [PDF]